• 1. Silver salts and DBU cooperatively catalyzed nucleophilic addition/cyclization of propargylic alcohols with trifluoromethyl ketones
  Jingjing Wang,Wei-Guang Kong,Feng Li,Jie Liu,Qin Shen,Lantao Liu,Wen-Xian Zhao Org. Biomol. Chem. 2015 13 5399

Professional Introduction to 1,3-Dioxolane,2-(trifluoromethyl) (CAS No: 2344-09-4)

1,3-Dioxolane,2-(trifluoromethyl), with the chemical formula C?H?F?O?, is a fluorinated dioxolane derivative that has garnered significant attention in the field of organic synthesis and pharmaceutical chemistry due to its unique structural and functional properties. This compound belongs to a class of heterocyclic compounds characterized by a five-membered oxygen-containing ring, which makes it a versatile intermediate in the synthesis of various bioactive molecules. The presence of a trifluoromethyl group at the 2-position enhances its reactivity and stability, making it particularly valuable in the development of advanced materials and drug candidates.

The CAS number 2344-09-4 uniquely identifies this compound in scientific literature and industrial applications. Its molecular structure consists of a dioxolane ring substituted with a trifluoromethyl group, which imparts specific electronic and steric effects that are highly beneficial in medicinal chemistry. The trifluoromethyl group is known to increase metabolic stability, lipophilicity, and binding affinity to biological targets, making it a preferred moiety in drug design.

In recent years, 1,3-dioxolane,2-(trifluoromethyl) has been extensively studied for its potential applications in the synthesis of novel pharmaceuticals. Researchers have leveraged its reactivity to develop new scaffolds for anti-inflammatory, antiviral, and anticancer agents. For instance, studies have demonstrated its utility in constructing complex molecular architectures that exhibit improved pharmacokinetic profiles compared to their non-fluorinated counterparts.

One of the most compelling aspects of 1,3-dioxolane,2-(trifluoromethyl) is its role as a key intermediate in the synthesis of fluorinated heterocycles. These heterocycles are increasingly recognized for their therapeutic potential due to their ability to modulate biological pathways effectively. The trifluoromethyl group enhances the compound's interaction with enzymes and receptors, leading to more potent and selective drug candidates. This has led to several preclinical studies exploring its applications in treating neurological disorders, where precise modulation of biological activity is crucial.

Advances in synthetic methodologies have further expanded the utility of 1,3-dioxolane,2-(trifluoromethyl). Modern techniques such as transition-metal-catalyzed cross-coupling reactions and organometallic chemistry have enabled the efficient construction of complex derivatives with tailored properties. These methods have opened new avenues for drug discovery by allowing chemists to modify the dioxolane core while retaining its inherent reactivity and biological relevance.

The pharmaceutical industry has been particularly interested in 1,3-dioxolane derivatives due to their potential as lead compounds for new therapeutics. The ability to fine-tune the electronic properties of these molecules through strategic substitution has led to several promising candidates entering clinical trials. For example, researchers have investigated analogs of 1,3-dioxolane,2-(trifluoromethyl) that exhibit potent inhibitory effects on enzymes involved in cancer progression.

In addition to pharmaceutical applications, 1,3-dioxolane,2-(trifluoromethyl) has shown promise in materials science. Its unique structural features make it a valuable building block for polymers and specialty chemicals that exhibit enhanced thermal stability and chemical resistance. These properties are particularly desirable in industrial settings where harsh conditions are encountered.

The synthesis of 1,3-dioxolane derivatives often involves multi-step processes that require careful optimization to ensure high yields and purity. Recent research has focused on developing greener synthetic routes that minimize waste and reduce environmental impact. Catalytic methods and solvent-free reactions have been explored as alternatives to traditional approaches, aligning with global efforts toward sustainable chemistry.

The role of computational chemistry in studying 1,3-dioxolane systems cannot be overstated. Molecular modeling techniques have provided insights into the interactions between these compounds and biological targets at an atomic level. This has facilitated the rational design of more effective drug candidates by predicting binding affinities and optimizing molecular structures before experimental validation.

Future research directions for 1,3-dioxolane derivatives include exploring their potential as probes for understanding disease mechanisms at a molecular level. By developing fluorescent or bioluminescent analogs of this compound series, scientists can gain deeper insights into cellular processes relevant to human health and disease.

In conclusion,1,3-Dioxolane,2-(trifluoromethyl) (CAS No: 2344-09-4) is a multifaceted compound with significant applications across pharmaceuticals and materials science. Its unique structural features make it an invaluable tool for synthetic chemists seeking to develop innovative therapeutics and advanced materials. As research continues to uncover new possibilities for this compound,its importance is likely to grow, driving further innovation in both academic and industrial settings.

• 148992-43-2(1-Ethoxy-2,2-difluoroethanol)
• 157055-31-7(Ethane, 1,1,1-triethoxy-2,2,2-trifluoro-)
• 31224-45-0(Ethane,2,2-diethoxy-1,1,1-trifluoro-)
• 431-46-9(Trifluoroacetaldehyde methyl hemiacetal)
• 433-27-2(Trifluoroacetaldehyde Ethyl Hemiacetal)
• 157055-35-1(Ethane, 1,1',1''-[ethylidynetris(oxy)]tris[2,2,2-trifluoro-)
• 130156-55-7(1,1,1-Trifluoro-2-(2-methoxyethoxy)methoxyethane)
• 42415-20-3(Trifluoroacetaldehyde Dimethyl Acetal)
• 55605-84-0(Ethanol, 2,2,2-trifluoro-1-(2,2,2-trifluoroethoxy)-)
• 157889-62-8(1,3,5-Trioxane, 2,4,6-tris(trifluoromethyl)-)